Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-10-09
2007-10-09
Angell, J. E. (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S069100, C435S069700, C435S252300, C435S320100, C435S325000
Reexamination Certificate
active
10431121
ABSTRACT:
The present invention relates to a highly efficient eukaryotic expression vector containing an exogenous transcription regulatory element which comprises a promoter/enhancer and the nucleotide sequence upstream of the translation initiation codon derived from human cytomegalovirus (HCMV) immediately early (IE) gene or human elongation factor 1α (EF1α) gene.
REFERENCES:
patent: 5830879 (1998-11-01), Isner
patent: 0 255 320 (1987-07-01), None
patent: WO 89/01036 (1989-02-01), None
patent: WO 00/40737 (2000-07-01), None
Dong Wan Kim, et al., “An efficient expression vector for stable expression in human live ”r Gene134 (1993), 307-308.
N. Wakabayashi-Ito, et al., “Characterization of the Regulatory Elements in the Promoter of the Human Elongation Factor 1-a Gene”, The Journal of Biological Chemistry, vol. 269, No. 47, Issue of Nov. 25, pp. 29831-29837, (1994).
J. Byun, et al., “Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy”, Gene Therapy (1996) 3, 780-788.
S. Takeshita, et al., “A Single Intraarterial Bolus of Vascular Endothelial Growth Factor Augments Revascularization in a Rabbit Ischemic Hind Limb Model”, Therapeutic Anglogenesis, vol. 93, Feb. 1994, 662-670 (1994).
Dong Wan Kim, et al., “Use of the human elongation factor 1a promoter as a versatile and efficient expression system”, Gene 91 (1990) 217-223.
BS Chapman, et al., “Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells”, Nucleic Acids Research, vol. 19, No. 14, 3979-3986, (1991).
Wirth Manfred, et al., “Construction of new expression vectors for mammalian cells using the immediate early enhancer of the human cytomegalovirus to increase expression from heterologous enhancer/promoters”, GBF Monographs, vol. 15, 1991, pp. 49-52, XP-001119558, Intl. workshop on Protein Glycosylation, Braunschweig, Germany, Jun. 28-30, 1990.
A. Akrigg, et al., “The structure of the major immediate early gene of human cytomegalovirus strain AD169”, Virus Research, 2 (1985) 107-121.
Addison et al., 1987, “Comparison of the human versus murine cytomegalovirus immediate early game promoters for transgene expression by adenoviral vectors”, Journal of General Virology 78:1853-1861.
Blegalke & Gaballe, 1991, “Sequence Requirements for Activation of the HIV-1 LTR by Human Cytomegalovirus”, Virology 183:381-385.
Cannon et al., 1996, “Murine Leukemia Virus-Based Tal-Inducible Long Terminal Repeat Replacement Vectors: a New System for Anti-Human Immunodeficiency Virus Gene Therapy”, Journal of Virology 70(11):8234-8240.
Damanla et al., 1998, “Simian Virus 40 Large T Antigen Stabilizes the TATA-Binding Protein-TFIIA Complex on the TATA Element”, Molecular and Cellular Biology 18(7):3926-3935.
DuBridge et al., 1987, “Analysis of Mutation in Human Cells by Using an Epstein-Barr Virus Shuttle System”, Molecular and Cellular Biology 7(1):379-387.
Gillinger & Alwine, 1993, “Transcriptional Activation by Simian Virus 40 Large T Antigen: Requirements for Simple Promoter Structures Containing either TATA or Initiator Elements with Variable Upstream Factor Binding Sites”, Journal of Virology 67(11):6882-6888.
Gruda et al., 1993, “Transcriptional Activation by Simian Virus 40 Large T Antigen: Interactions with Multiple Component of the Transcription Complex”, Molecular and Cellular Biology 13(2):981-989.
Kim et al., 1998, “Construction of Retroviral Vectors with Improved Safety, Gene Expression, and Versatility”, Journal of Virology 72(2):984-1004.
Kozak, 1991, “Structural Features In Eukaryatic mRNAs that Modulate the Initiation of Translation”, Journal of Biological Chemistry 256(30):19867-19870.
Takekoshi et al., 1998, “Use of a Glycoprotein gB Promoter for Expression of Genes Inserted into the Human Cytomegalovirus Genoma”, Total J. Exp. Clin. Med., 23(1):37-42.
Uetsuki et al, 1989, “Isolation and Characterization of the Human Chromosomal Gene for Polypeptide Chain Elongation Factor-1α”, Journal of Biological Chemistry 264(10):5791-5798.
Kim Sun-young
Yu Seung-Shin
Anderson Kill & Olick PC
Angell J. E.
ViroMed Limited
LandOfFree
Highly efficient eukaryotic expression vector comprising an... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Highly efficient eukaryotic expression vector comprising an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Highly efficient eukaryotic expression vector comprising an... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3843690